Study evaluates the connection between sentinel lymph node study and molecular profile in breast cancer patients after neoadjuvant therapy, highlighting critical implications.
Lymphoscintigraphy (LS)/sentinel lymph node (SLN) study is one of the controversial issues in patients with breast cancer who have undergone neoadjuvant therapy (NAT). The aim of our study is to investigate the value of LS/SLN study after NAT and to evaluate its relationship with the molecular profile in breast cancer.
No takes yet. Share an insight, caveat, or question.
Uçmak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: